172 related articles for article (PubMed ID: 29985744)
1. Incorporating a companion test into the noninferiority design of medical device trials.
Lu NT; Xu Y; Yang Y
J Biopharm Stat; 2019; 29(1):143-150. PubMed ID: 29985744
[TBL] [Abstract][Full Text] [Related]
2. Mixed noninferiority margin and statistical tests in active controlled trials.
Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
[TBL] [Abstract][Full Text] [Related]
3. Rationale for and methods of superiority, noninferiority, or equivalence designs in orthopaedic, controlled trials.
Vavken P
Clin Orthop Relat Res; 2011 Sep; 469(9):2645-53. PubMed ID: 21246313
[TBL] [Abstract][Full Text] [Related]
4. Noninferiority testing for matched-pair ordinal data with misclassification.
Han Y; Lu ZH; Poon WY
Stat Med; 2019 Dec; 38(28):5332-5349. PubMed ID: 31637752
[TBL] [Abstract][Full Text] [Related]
5. Defining the noninferiority margin and analysing noninferiority: An overview.
Althunian TA; de Boer A; Groenwold RHH; Klungel OH
Br J Clin Pharmacol; 2017 Aug; 83(8):1636-1642. PubMed ID: 28252213
[TBL] [Abstract][Full Text] [Related]
6. One-tailed asymptotic inferences for the difference of proportions: Analysis of 97 methods of inference.
Hernández MÁ; Andrés AM; Tejedor IH
J Biopharm Stat; 2018; 28(6):1090-1104. PubMed ID: 29608389
[TBL] [Abstract][Full Text] [Related]
7. Some issues for the evaluation of noninferiority trials.
Xie X; Wang M; Ng V; Sikich N
J Comp Eff Res; 2018 Sep; 7(9):835-843. PubMed ID: 30192159
[TBL] [Abstract][Full Text] [Related]
8. Notes on testing noninferiority in multivariate binary data under the matched-pair design.
Lui KJ; Chang KC
Stat Methods Med Res; 2016 Aug; 25(4):1272-89. PubMed ID: 23487018
[TBL] [Abstract][Full Text] [Related]
9. Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness.
Olliaro PL; Vaillant M
PLoS Med; 2019 Jul; 16(7):e1002850. PubMed ID: 31299047
[TBL] [Abstract][Full Text] [Related]
10. How to demonstrate similarity by using noninferiority and equivalence statistical testing in radiology research.
Ahn S; Park SH; Lee KH
Radiology; 2013 May; 267(2):328-38. PubMed ID: 23610094
[TBL] [Abstract][Full Text] [Related]
11. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test.
Doi M; Takahashi F; Kawasaki Y
Stat Med; 2017 Dec; 36(30):4789-4803. PubMed ID: 28960376
[TBL] [Abstract][Full Text] [Related]
12. Choice of delta noninferiority margin and dependency of the noninferiority trials.
Tsong Y; Zhang J; Levenson M
J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
[TBL] [Abstract][Full Text] [Related]
13. Hypotheses and type I error in active-control noninferiority trials.
Chen G; Wang YC; Chi GY
J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the Regulatory Dialogue Between Pharmaceutical Companies and the European Medicines Agency on the Choice of Noninferiority Margins.
Althunian TA; de Boer A; Mantel-Teeuwisse AK; Groenwold RHH; Gispen-de Wied CC; Leufkens HGM; Klungel OH
Clin Ther; 2020 Aug; 42(8):1588-1594. PubMed ID: 32782135
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
Tsong Y; Zhang J
J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
[TBL] [Abstract][Full Text] [Related]
16. Using a single noninferiority margin or preserved fraction for an entire pharmacological class was found to be inappropriate.
Althunian TA; de Boer A; Groenwold RHH; Klungel OH
J Clin Epidemiol; 2018 Dec; 104():15-23. PubMed ID: 30009941
[TBL] [Abstract][Full Text] [Related]
17. Most noninferiority trials were not designed to preserve active comparator treatment effects.
Tsui M; Rehal S; Jairath V; Kahan BC
J Clin Epidemiol; 2019 Jun; 110():82-89. PubMed ID: 30858020
[TBL] [Abstract][Full Text] [Related]
18. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
Kaul S; Diamond GA
Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
[TBL] [Abstract][Full Text] [Related]
19. Noninferiority Trial Design: Opportunities and Challenges.
Adidharma W; Nguyen SN; Waljee JF
J Hand Surg Am; 2022 Nov; 47(11):1101-1106. PubMed ID: 36182582
[TBL] [Abstract][Full Text] [Related]
20. Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials.
Aberegg SK; Hersh AM; Samore MH
J Gen Intern Med; 2018 Jan; 33(1):88-96. PubMed ID: 28875400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
